Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - INTEREST INCOME & EXPENSE
Interest Income & Expense ANAB - AnaptysBio, Inc.
18.1 M
LAST VALUE
253.14%
2 YEAR CAGR
61.38%
5 YEAR CAGR
35.20%
10 YEAR CAGR